Rare diseases
Investigational molecules
Locations
Back to Spain132 clinical trials in Jaen, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
SpainStudy on Home Administration of Pertuzumab and Trastuzumab for Patients with Early or Locally Advanced HER2-Positive Breast Cancer
SpainStudy Comparing Selpercatinib with a Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer
SpainStudy of Chemotherapy vs. Nivolumab for Patients with Resectable Non-Small Cell Lung Cancer
SpainStudy of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae
SpainStudy of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
SpainStudy of Nivolumab and Ipilimumab with Chemotherapy for Patients with Stage IV Non-Small Cell Lung Cancer and Brain Metastases
SpainStudy on Noradrenaline and Terlipressin for Treating Septic Shock in Patients
SpainStudy on Eye Health During Treatment with Mirvetuximab Soravtansine, Brimonidine Tartrate, and Prednisolone Acetate for Patients with Recurrent Ovarian Cancer
SpainStudy on Sotorasib for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with KRAS Mutation
SpainStudy on the Effectiveness and Safety of Trastuzumab, Tucatinib, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer
SpainStudy of Eftilagimod Alpha and Paclitaxel in Patients with HER2-Negative/Low Metastatic Breast Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Multiple studies focusing on non-small cell lung cancer and small cell lung cancer treatments, investigating novel combination therapies and targeted approaches for different disease stages.
Research emphasizes improving survival rates through innovative therapeutic approaches for both extensive and limited-stage disease.
Comprehensive research into HER2-positive and hormone receptor-positive breast cancer, exploring new treatment combinations and targeted therapies.
Studies focus on both early-stage and metastatic disease, with emphasis on personalized treatment approaches.
Diverse research covering hepatocellular carcinoma, bladder cancer, and other solid tumors, evaluating novel therapeutic strategies.
Investigations aim to improve treatment outcomes across multiple cancer types using cutting-edge therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
